Alpha PSMA & New Targets in Prostate Cancer | ProsTIC/PCF Global Webinar Link

[marnieg46]

Please find below the link to the recent, very comprehensive and interesting podcast. It's provided for the members of HU who have contacted me and indicated that either the time of the presentation didn't suit or they didn't have access to the web platform and also for any other members of FPC who might find some of the content relevant.

As my initial post on APC about this webinar was deleted by one of the moderators and I received a reprimand, I'd be very grateful if you would PM the link to any of your contacts on that site if you think the content might be of interest to them.

A number of issues are discussed in the podcast apart from lutetium and those wanting to keep abreast of the recent research in prostate cancer will find it relevant.

Although not much is posted on HU in relation to neuroendocrine prostate cancer (NEPC), I personally found Mike Morris's comment that some 15-20% of mCRPC men will develop this condition a salient reminder of what is in store for quite a reasonable percentage of men who are CR.

After watching the podcast I received two comments one from a friend and one from my husband that they thought that lead may very well be the future. As I found the webinar needed a reasonably good scientific understanding (which I don't possess), perhaps those members who are skilled at interpreting the science into plain English might find the time to do a short précis for any like me.

This is the outline from the webinar:

"We peek into theranostics beyond what we currently have with beta-emitters like LuPSMA, into the tantalising world of alpha-PSMA theranostics. Multidisciplinary researchers from the PCF-funded TACTICAL project give a sneak into current and future work.

Hear from Memorial Sloan Kettering Cancer Center experts Prof Mike Morris, Dr Lisa Bodei and Dr Jason Lewis about very exciting developments in DLL3 imaging and theranostics in neuroendocrine prostate cancer; Dr Marwa Rahimi (Radiochemist at Peter MacCallum Cancer Centre) and David Pattison (Nuclear Medicine Physician, Royal Brisbane Hospital), overview Lead-212 targeted alpha therapy; and Dr Megan Crumbaker (Medical Oncologist (St Vincent's Hoapital, Sydney) who discusses Actinium-225 clinical data.

Plus Dr James Buteau (Nuclear Medicine Physician, Peter Mac) on the Q&A Co-hosted by Declan Murphy and Michael Hofman from the GU Cast studio in Melbourne. along with Dr Howard Soule and Dr Andrea Miyahira from the PCF in California."

youtu.be/Vpb6KRWow0U(Not working as expected?)

[KocoPr]

Thanks for posting I’ll watch it on soon

[NickJoy]

I watched it on YouTube and found it really interesting. Thank you so much for keeping us in the loop with this.

[d3is4me]

Marnie

Thanks for a great outline of the webinar.

I cannot understand why the post was deleted on APC

At the risk of being criticized or deleted I will have my rant I am amazed at how many posts and replies on APC are on QAL food/ photos etc and testosterone recovery but \ future PC treatments /Theranostics seem to get little attention is it because Germany and Australia are leaders in this field??

[d3is4me]

Thanks Marnie

I would have thought that advertisements were something that would give financial gain???

It looks like it will be a good weekend.

Cheers

[marnieg46 in reply to d3is4me]

I deleted my reply to you...terrified of being banned 🙄. I'll frame a more nuanced response...

[Bethpage]

Thank you for posting. I watched on schedule. I also do not possess a "reasonably good scientific understanding," I am hoping that a repeated (or two) view might improve my understanding.

[marnieg46 in reply to Bethpage]

I'm with you there!!

[lcfcpolo]

Thank you Marnie for posting this video. I missed the live webcast and had been unable to find it. Brilliant discussion. Writing from the UK but you Aussies and the Germans are just so far ahead. Go Aussie and have a great weekend (except for the cricket lol).

[marnieg46]

Glad you found it interesting.

Oh I think the cricket might be over. Just watching the fifth test as I reply but I think we have it wrapped up!!